Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells

致癌突触:细胞与细胞的接触使胰腺癌和成纤维基质细胞之间基于 Trogocytic 的代谢相互作用成为可能

基本信息

  • 批准号:
    9894770
  • 负责人:
  • 金额:
    $ 20.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-15 至 2021-02-28
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The project titled “Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells” directly addresses the NCI Provocative Question (PQ) #7 in seeking advancement in understanding of the pathognomonic significance and functions of newly described synapse-like heterotypic cell-cell contacts formed between carcinoma cells and cancer-associated fibroblasts (CAFs). CAFs are known to provide cancer cells with nutrients and reciprocally- induced signaling inputs. Pancreatic cancer (PC), particularly pancreatic ductal adenocarcinoma, is an extreme example of preponderance of stroma in which particular CAF characteristics confer negative prognosis. Our combined and highly complementary preliminary findings serve as a basis to study the previously uncharacterized heterotypic cell-cell “oncogenic synapse” structure and its PC supportive function. Two specific aims will test the hypothesis that PC cells depend on NTNG1-NGL1 engagement to form oncogenic synapses and consume cholesterol via Wnt5a-regulated Ca2+ and phosphatidylserine (PtdSer)-dependent trogocytosis. Aim 1 will define the molecular requirements for NTNG1-NGL1 engagement and functional oncogenic synapse formation. Molecular engineering of NTNG1 and NGL1 proteins and microscopy imaging will define the structural and functional particulars of the oncogenic synapses formed between CAF and PC cells. Aim 2 will determine the importance of NTNG1/NGL1-mediated oncogenic synapses in trogocytosis. Based on preliminary experiments, we will test if NTNG1-NGL1 engagement is needed for the PC cell-executed trogocytosis. The cell-cell contact structures involved in the CAF-PC oncogenic synapses that facilitate trogocytosis have not been previously described. Therefore, their detailed molecular and cell biology characterization is critical. The adaptation of neuronal synapse mechanisms by PC cells bypasses the metabolic restrictions imposed by the PC microenvironment. Thus, the oncogenic synapses may be the key to understanding the direct CAF-PC cell- cell communication which endorses malignant progression.
项目总结/摘要 该项目名为“致癌突触:细胞与细胞接触, 胰腺癌和成纤维基质细胞之间的相互作用”直接解决了NCI 挑衅性问题(PQ)#7,以寻求进一步理解病理学意义, 新描述的在癌细胞之间形成的突触样异型细胞-细胞接触的功能, 癌相关成纤维细胞(CAF)。已知CAF为癌细胞提供营养和维生素, 诱导信号输入。胰腺癌(PC),特别是胰腺导管腺癌,是一种极端的癌症。 间质优势的例子,其中特定的CAF特征赋予阴性预后。我们 综合和高度互补的初步调查结果作为研究以前的基础, 未表征的异型细胞-细胞“致癌突触”结构及其PC支持功能。两个具体 目的是检验PC细胞依赖于NTNG 1-NGL 1接合形成致癌突触的假设 并通过Wnt 5a调节的Ca 2+和磷脂酰丝氨酸(PtdSer)依赖性胞饮作用消耗胆固醇。 目的1将明确NTNG 1-NGL 1结合和功能性致癌突触的分子要求 阵NTNG 1和NGL 1蛋白的分子工程和显微成像将确定结构 以及CAF和PC细胞之间形成的致癌突触的功能细节。 目的2将确定NTNG 1/NGL 1介导的致癌突触在胞啃中的重要性。基于 在初步实验中,我们将测试NTNG 1-NGL 1接合是否需要PC细胞执行 胞啃 参与CAF-PC致癌突触的细胞-细胞接触结构促进了胞吞作用, 以前描述过。因此,其详细的分子和细胞生物学表征至关重要。的 PC细胞对神经元突触机制的适应绕过了 PC微环境。因此,致癌性突触可能是理解CAF-PC细胞直接作用的关键。 支持恶性进展的细胞通讯。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Igor Astsaturov其他文献

Igor Astsaturov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Igor Astsaturov', 18)}}的其他基金

A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
CBL0137 联合 Ipilimumab 和 Nivolumab 治疗局部晚期或转移性黑色素瘤的 I 期概念验证研究
  • 批准号:
    10722873
  • 财政年份:
    2023
  • 资助金额:
    $ 20.05万
  • 项目类别:
Neoadjuvant Stroma Modification in Pancreatic Cancer
胰腺癌的新辅助基质修饰
  • 批准号:
    10199321
  • 财政年份:
    2021
  • 资助金额:
    $ 20.05万
  • 项目类别:
Neoadjuvant Stroma Modification in Pancreatic Cancer
胰腺癌的新辅助基质修饰
  • 批准号:
    10459402
  • 财政年份:
    2021
  • 资助金额:
    $ 20.05万
  • 项目类别:
Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer
癌症中胆固醇代谢和 EGFR 信号传导的协同靶向
  • 批准号:
    9335800
  • 财政年份:
    2014
  • 资助金额:
    $ 20.05万
  • 项目类别:
Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer
癌症中胆固醇代谢和 EGFR 信号传导的协同靶向
  • 批准号:
    8930103
  • 财政年份:
    2014
  • 资助金额:
    $ 20.05万
  • 项目类别:
Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer
癌症中胆固醇代谢和 EGFR 信号传导的协同靶向
  • 批准号:
    8837225
  • 财政年份:
    2014
  • 资助金额:
    $ 20.05万
  • 项目类别:
Targeting Sterol Gene SC4MOL and EGFR as Synergistic Anti-Cancer Strategy
靶向甾醇基因 SC4MOL 和 EGFR 作为协同抗癌策略
  • 批准号:
    8723411
  • 财政年份:
    2013
  • 资助金额:
    $ 20.05万
  • 项目类别:
Regulation of EGFR by SC4MOL- and NSDHL-Dependent Trafficking
SC4MOL 和 NSDHL 依赖性贩运对 EGFR 的调节
  • 批准号:
    8537870
  • 财政年份:
    2012
  • 资助金额:
    $ 20.05万
  • 项目类别:
Regulation of EGFR by SC4MOL- and NSDHL-Dependent Trafficking
SC4MOL 和 NSDHL 依赖性贩运对 EGFR 的调节
  • 批准号:
    8223653
  • 财政年份:
    2012
  • 资助金额:
    $ 20.05万
  • 项目类别:
Targeting Sterol Gene SC4MOL and EGFR as Synergistic Anti-Cancer Strategy
靶向甾醇基因 SC4MOL 和 EGFR 作为协同抗癌策略
  • 批准号:
    8293041
  • 财政年份:
    2011
  • 资助金额:
    $ 20.05万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.05万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了